TABLE 6.

Benefit-cost ratios and sensitivity analysis

	Benefit-cost ratios*
Discount rate (%)	Ministry of health	Society
Primary analysis
5	6.34	3.25
Secondary analysis
0	8.99	4.61
3	7.08	3.64
7	5.84	3.00

^*Benefit-cost ratios were calculated by dividing the cost saved from disease averted with a second dose program less the cost averted with the single dose program by the total cost of implementing a program for a second dose of measles, mumps and rubella vaccine at 18 months minus the cost of the program for a single dose